APA (7th ed.) Citation

CY, C., MS, H., MY, C., YW, T., CL, L., CW, H., . . . HW, C. (2026). Lipid nanoparticle-formulated DNA acts as a potent immune modulator for cancer immunotherapy through interferon signaling pathways. Theranostics, 16(5), 2342. https://doi.org/10.7150/thno.121364

Chicago Style (17th ed.) Citation

CY, Chiang, et al. "Lipid Nanoparticle-formulated DNA Acts as a Potent Immune Modulator for Cancer Immunotherapy Through Interferon Signaling Pathways." Theranostics 16, no. 5 (2026): 2342. https://doi.org/10.7150/thno.121364.

MLA (9th ed.) Citation

CY, Chiang, et al. "Lipid Nanoparticle-formulated DNA Acts as a Potent Immune Modulator for Cancer Immunotherapy Through Interferon Signaling Pathways." Theranostics, vol. 16, no. 5, 2026, p. 2342, https://doi.org/10.7150/thno.121364.